Balchem (BCPC) EBITDA Margin (2010 - 2026)

Balchem (BCPC) has 17 years of EBITDA Margin data on file, last reported at 20.55% in Q1 2026.

• On a quarterly basis, EBITDA Margin rose 18.0% year-over-year to 20.55% in Q1 2026; TTM through Mar 2026 was 20.23%, a 30.0% increase from a year earlier, with the FY2025 full-year figure at 20.18%, up 100.0% from the prior year.
• EBITDA Margin for Q1 2026 stood at 20.55%, up from 19.84% in the prior quarter.
• Over the last five years, EBITDA Margin for BCPC reached as high as 20.55% in Q1 2026 and fell as low as 13.77% in Q3 2022.
• Historically, EBITDA Margin has averaged 18.16% across 5 years, with a median of 18.97% in 2023.
• Across the five-year window, EBITDA Margin slumped 267 bps in 2022 and jumped 520 bps in 2023, its largest moves.
• Year by year, EBITDA Margin stood at 14.32% in 2022, then increased by 17 bps to 16.76% in 2023, then increased by 18 bps to 19.77% in 2024, then climbed by 0 bps to 19.84% in 2025, then increased by 4 bps to 20.55% in 2026.
• Per Business Quant data, the three most recent EBITDA Margin figures were 20.55% in Q1 2026, 19.84% in Q4 2025, and 20.4% in Q3 2025.